DOST prepares for WHO vaccine trials, unveils research programs

DOST continues preparations for WHO solidarity vaccine trials and unveils major research programs to combat COVID-19.

The Philippines awaits the WHO's formal announcement to begin the global study, with hospital sites, teams, and supplies already prepared.

WHO ensures all participating countries are ready before launching the trial, considering new variants and updating protocols.

Objectives of the trial include determining vaccine effectiveness against local variants for participants aged 16 and above.

DOST also receives applications for independent clinical trials including younger age groups and those with HIV.